Section Arrow
PODD.NASDAQ
- Insulet Corp
Quotes are at least 15-min delayed:2025/06/28 14:59 EDT
Last
 313.08
+3.25 (+1.05%)
Day High 
313.35 
Prev. Close
309.83 
1-M High
329.1018 
Volume 
760.29K 
Bid
299
Ask
313.08
Day Low
305.07 
Open
309.4 
1-M Low
295.56 
Market Cap 
21.80B 
Currency USD 
P/E 55.83 
%Yield -- 
10-SMA 305.88 
20-SMA 310.53 
50-SMA 294.07 
52-W High 329.33 
52-W Low 173 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
5.55/5.22
Enterprise Value
23.10B
Balance Sheet
Book Value Per Share
18.91
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
2.07B
Operating Revenue Per Share
22.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 14:59 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.